First Time Loading...
R

Redx Pharma PLC
LSE:REDX

Watchlist Manager
Redx Pharma PLC
LSE:REDX
Watchlist
Price: 8.06 GBX -19.4%
Updated: Apr 26, 2024

Intrinsic Value

REDX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Redx Pharma Plc engages in the discovery and development of proprietary, small molecule drugs to address areas of high, unmet medical need. [ Read More ]

The intrinsic value of one REDX stock under the Base Case scenario is 8.98 GBX. Compared to the current market price of 8.06 GBX, Redx Pharma PLC is Undervalued by 10%.

Key Points:
REDX Intrinsic Value
Base Case
8.98 GBX
Undervaluation 10%
Intrinsic Value
Price
R
Worst Case
Base Case
Best Case

Valuation Backtest
Redx Pharma PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling REDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Redx Pharma PLC

Provide an overview of the primary business activities
of Redx Pharma PLC.

What unique competitive advantages
does Redx Pharma PLC hold over its rivals?

What risks and challenges
does Redx Pharma PLC face in the near future?

Summarize the latest earnings call
of Redx Pharma PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Redx Pharma PLC.

Provide P/S
for Redx Pharma PLC.

Provide P/E
for Redx Pharma PLC.

Provide P/OCF
for Redx Pharma PLC.

Provide P/FCFE
for Redx Pharma PLC.

Provide P/B
for Redx Pharma PLC.

Provide EV/S
for Redx Pharma PLC.

Provide EV/GP
for Redx Pharma PLC.

Provide EV/EBITDA
for Redx Pharma PLC.

Provide EV/EBIT
for Redx Pharma PLC.

Provide EV/OCF
for Redx Pharma PLC.

Provide EV/FCFF
for Redx Pharma PLC.

Provide EV/IC
for Redx Pharma PLC.

Show me price targets
for Redx Pharma PLC made by professional analysts.

What are the Revenue projections
for Redx Pharma PLC?

How accurate were the past Revenue estimates
for Redx Pharma PLC?

What are the Net Income projections
for Redx Pharma PLC?

How accurate were the past Net Income estimates
for Redx Pharma PLC?

What are the EPS projections
for Redx Pharma PLC?

How accurate were the past EPS estimates
for Redx Pharma PLC?

What are the EBIT projections
for Redx Pharma PLC?

How accurate were the past EBIT estimates
for Redx Pharma PLC?

Compare the revenue forecasts
for Redx Pharma PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Redx Pharma PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Redx Pharma PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Redx Pharma PLC compared to its peers.

Compare the P/E ratios
of Redx Pharma PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Redx Pharma PLC with its peers.

Analyze the financial leverage
of Redx Pharma PLC compared to its main competitors.

Show all profitability ratios
for Redx Pharma PLC.

Provide ROE
for Redx Pharma PLC.

Provide ROA
for Redx Pharma PLC.

Provide ROIC
for Redx Pharma PLC.

Provide ROCE
for Redx Pharma PLC.

Provide Gross Margin
for Redx Pharma PLC.

Provide Operating Margin
for Redx Pharma PLC.

Provide Net Margin
for Redx Pharma PLC.

Provide FCF Margin
for Redx Pharma PLC.

Show all solvency ratios
for Redx Pharma PLC.

Provide D/E Ratio
for Redx Pharma PLC.

Provide D/A Ratio
for Redx Pharma PLC.

Provide Interest Coverage Ratio
for Redx Pharma PLC.

Provide Altman Z-Score Ratio
for Redx Pharma PLC.

Provide Quick Ratio
for Redx Pharma PLC.

Provide Current Ratio
for Redx Pharma PLC.

Provide Cash Ratio
for Redx Pharma PLC.

What is the historical Revenue growth
over the last 5 years for Redx Pharma PLC?

What is the historical Net Income growth
over the last 5 years for Redx Pharma PLC?

What is the current Free Cash Flow
of Redx Pharma PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Redx Pharma PLC.

Financials

Balance Sheet Decomposition
Redx Pharma PLC

Current Assets 23.3m
Cash & Short-Term Investments 18.1m
Receivables 5.2m
Non-Current Assets 2.3m
PP&E 1.9m
Intangibles 394k
Current Liabilities 21m
Accounts Payable 3.8m
Short-Term Debt 15.7m
Other Current Liabilities 1.5m
Non-Current Liabilities 1.3m
Long-Term Debt 1.3m
Efficiency

Earnings Waterfall
Redx Pharma PLC

Revenue
4.2m GBP
Operating Expenses
-35.2m GBP
Operating Income
-31m GBP
Other Expenses
-2.2m GBP
Net Income
-33.2m GBP

Free Cash Flow Analysis
Redx Pharma PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

REDX Profitability Score
Profitability Due Diligence

Redx Pharma PLC's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

12/100
Profitability
Score

Redx Pharma PLC's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

REDX Solvency Score
Solvency Due Diligence

Redx Pharma PLC's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
High D/E
35/100
Solvency
Score

Redx Pharma PLC's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

REDX Price Targets Summary
Redx Pharma PLC

There are no price targets for REDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

REDX Price
Redx Pharma PLC

1M 1M
-57%
6M 6M
-69%
1Y 1Y
-74%
3Y 3Y
-87%
5Y 5Y
+34%
10Y 10Y
-91%
Annual Price Range
8.06
52w Low
4.25
52w High
36
Price Metrics
Average Annual Return 180.13%
Standard Deviation of Annual Returns 335.38%
Max Drawdown -97%
Shares Statistics
Market Capitalization 31.4m GBX
Shares Outstanding 388 985 984
Percentage of Shares Shorted
N/A

REDX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Redx Pharma PLC

Country

United Kingdom

Industry

Pharmaceuticals

Market Cap

31.4m GBP

Dividend Yield

0%

Description

Redx Pharma Plc engages in the discovery and development of proprietary, small molecule drugs to address areas of high, unmet medical need. The company is headquartered in Macclesfield, Cheshire and currently employs 71 full-time employees. The company went IPO on 2015-03-27. The Company’s product pipeline includes RXC004 and ROC007. Its lead product candidate RXC004, which is a potent, selective, oral small molecule inhibitor of the enzyme, Porcupine, a key activator of Wnt ligands in the Wnt signalling pathway. RXC004 is in Phase I study in combination with nivolumab (OPDIVO- Bristol Myers Squibb, an anti-PD-1 antibody). The RXC007 is a selective small molecule inhibitor that targets Rho Associated Coiled-Coil Containing Protein Kinase 2 (ROCK2) which sits at a nodal point in a cell signaling pathway. RXC007 is used for the treatment of fibrotic diseases.

Contact

CHESHIRE
Macclesfield
Block 33, Mereside,, Alderley Park
+441625469900.0
https://www.redxpharma.com/

IPO

2015-03-27

Employees

71

Officers

CEO & Executive Director
Ms. Lisa Mary Whewell Anson
Chief Financial Officer
Mr. Peter J. Collum
Chief Operating Officer
Dr. James Mead
Chief Scientific Officer
Dr. Richard Armer
Head of Investor Relations
Dr. Karl Hard Ph.D.
General Counsel & Company Secretary
Ms. Claire Penelope Solk
Show More
Head of Communications
Ms. Caitlin Pearson
Senior Vice President of Chemistry, DMPK & Intellectual Property
Dr. Cliff Jones
Senior Vice President of Biology
Dr. Caroline Phillips
Head of Development Operations
Mr. Craig Tilston
Show Less

See Also

Discover More
What is the Intrinsic Value of one REDX stock?

The intrinsic value of one REDX stock under the Base Case scenario is 8.98 GBX.

Is REDX stock undervalued or overvalued?

Compared to the current market price of 8.06 GBX, Redx Pharma PLC is Undervalued by 10%.